[go: up one dir, main page]

CN1324010C - Preparation of miglitol - Google Patents

Preparation of miglitol Download PDF

Info

Publication number
CN1324010C
CN1324010C CNB2005100376754A CN200510037675A CN1324010C CN 1324010 C CN1324010 C CN 1324010C CN B2005100376754 A CNB2005100376754 A CN B2005100376754A CN 200510037675 A CN200510037675 A CN 200510037675A CN 1324010 C CN1324010 C CN 1324010C
Authority
CN
China
Prior art keywords
formula
ester
reaction
phenylalanine
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005100376754A
Other languages
Chinese (zh)
Other versions
CN1680321A (en
Inventor
苏国强
柴玉柱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Provincial Institute of Materia Medica Co Ltd
Original Assignee
Jiangsu Provincial Institute of Materia Medica Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Provincial Institute of Materia Medica Co Ltd filed Critical Jiangsu Provincial Institute of Materia Medica Co Ltd
Priority to CNB2005100376754A priority Critical patent/CN1324010C/en
Publication of CN1680321A publication Critical patent/CN1680321A/en
Application granted granted Critical
Publication of CN1324010C publication Critical patent/CN1324010C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a preparing method of mitiglinide, which is characterized in that a chiral center is provided by L-phenylalanine, and a chemical separating method or an asymmetric hydrogenation method is avoided. The method of the present invention has high efficiency and good optical purity.

Description

A kind of preparation method of mitiglinide
Technical field
The present invention relates to a kind of preparation method of mitiglinide.
Background technology
Mitiglinide is an antidiabetic drug, and its mechanism of action is similar to sulfonylurea hypoglycemic agent, mainly acts on the ATP susceptibility K of beta cell +Passage promotes insulin secretion.The mitiglinide preparation method is many, mainly contains chemical resolution method and asymmetric hydrogenation method.
Chemical resolution method has the R-isomer of half to utilize, and yield is low, cost height (method 1).The expensive rhodium complex of asymmetric hydrogenation method needs (rhodium/(2S, 4S)-N-butoxy carbonyl-4-diphenylphosphino-2-diphenylphosphino crassitude), make production cost improve greatly, be unfavorable for suitability for industrialized production (method 2).
Method 1: chemical resolution method
Method 2: asymmetric hydrogenation method
Summary of the invention
The object of the invention provides a kind of preparation method of mitiglinide, and its chiral carbon atom provides chirality by the L-phenylalanine.
Purpose of the present invention can reach by following measure:
X is chlorine, bromine halogen atom among its Chinese style II, and Z and Z` are cyano group, ester group or amide group in the formula III.
The present invention has following advantage compared to existing technology:
Chiral carbon atom in the mitiglinide is provided by the L-phenylalanine, avoided chemical resolution method to have the R-isomer of half to utilize, and the expensive rhodium complex of asymmetric hydrogenation method needs (rhodium/(2S, 4S)-N-butoxy carbonyl-4-diphenylphosphino-2-diphenylphosphino crassitude).The starting material that the inventive method adopted are cheap and easy to get, the processing condition gentleness, and the optical purity of products height is convenient to suitability for industrialized production.
Embodiment
Embodiment 1
(S)-2-chlorobenzene propionic acid
In the 5000ml reaction flask, add 6N hydrochloric acid 3000ml, cryosel is bathed cooling and is added L-phenylalanine-3,4-quinone 30g (2mol) down, stir, drip 36% sodium nitrite in aqueous solution 850g below 0 ℃, drip off room temperature reaction and spend the night, tell little yellow organic layer, water layer merges and adds an amount of anhydrous sodium sulfate drying with ethyl acetate extraction.Remove ethyl acetate under reduced pressure, get the about 360g of little yellow raffinate, [α] D 20=+4.5 ° (methyl alcohol), yield 97.5% (directly the next step).
(S)-2-chlorobenzene ethyl propionate
In the 3000ml reaction flask, add (S)-2-chloro-3-phenylpropionic acid 351g (1.90mol), methylene dichloride 770ml, 98% sulfuric acid 7.8ml, the ice bath cooling drips dehydrated alcohol 1000ml down, drip off stirring at room reaction 48hr, the washing of 2N saleratus water liquid, anhydrous sodium sulfate drying, decompression is steamed to slip and is collected 118~122 ℃/5mmHg cut 282.5g, yield 70.0%, [α] D 20=+18.6 ° (dehydrated alcohol).
(S)-the 2-bromo-hydrocinnamic acid
In the 3000ml reaction flask, add 6N hydrochloric acid 1500ml, cryosel is bathed cooling and is added L-phenylalanine 165g (1mol) down, stir, drip 20% sodium nitrite in aqueous solution 500g below 0 ℃, drip off room temperature reaction and spend the night, tell little yellow organic layer, water layer merges and adds an amount of anhydrous sodium sulfate drying with ethyl acetate extraction.Remove ethyl acetate under reduced pressure, get the about 200g of little yellow raffinate, [α] D 20=-9.5 ° (methyl alcohol).
(S)-2-bromo-hydrocinnamic acid ethyl ester
Method is with (S)-2-chlorobenzene ethyl propionate, yield 65%, [α] D 20=+8.6 ° (methylene dichloride).
Embodiment 2
(S)-2-benzyl Succinic Acid
In the 1000ml reaction flask, add anhydrous N, dinethylformamide 625ml, activity methene compound (0.4mol), cryosel is bathed to be cooled to and is added 50% sodium hydrogen 48g (1mol) below 0 ℃, stir down and drip (S)-2-halo-3-phenylpropionic acid ethyl ester (0.4mol), keep cryosel and bathe stirring reaction 30min, again in stirring at room.In the about 500g trash ice of reaction solution impouring, ethyl acetate extraction, anhydrous sodium sulfate drying, remove solvent under reduced pressure, get the yellowish brown raffinate, add acetate 400ml, 37% hydrochloric acid 400ml, heating reflux reaction, be evaporated to small volume, crystallization spends the night in the impouring trash ice, gets white solid (the results are shown in Table 1).
Figure C20051003767500051
Formula II Formula III Reaction times Yield Specific optical rotation (ethyl acetate)
X=Cl Z=CN;Z`=COOEt 6h 55% -27.8°
X=Br Z=CN;Z`=COOEt 4h 68% -28.4°
X=Cl Z=Z`=CN 6h 75% -28.5°
X=Br Z=Z`=CN 6h 83% -27.9°
X=Cl Z=Z`=COOEt 8h 43% -23.6°
Embodiment 3
(S)-2-benzyl Succinic anhydried
In the 1000ml reaction flask, add (S)-2-benzyl Succinic Acid 62.5g (0.3mol), diacetyl oxide 220ml (2.33mol), in 75-80 ℃ of reaction 1hr.Cooling back adds the about 415ml of isopropyl ether, puts that crystallization spends the night in the refrigerator, gets white solid 39.7g, and mp122-125 ℃, yield 69.6%, [α] D 20=+55.6 ° (ethyl acetate).
Embodiment 4
Mitiglinide
In the 1000ml reaction flask, add (S)-2-benzyl Succinic anhydried 38.0g (0.20mol), methylene dichloride 815ml, cryosel is bathed cooling, drips (cis)-hexahydroisoindoline, and room temperature reaction 2hr, concentrating under reduced pressure get light yellow dope 89g, [α] D 20=-3.5 ° (C=1.0, methyl alcohol).
The mitiglinide calcium salt
In the 1000ml reaction flask, mitiglinide 89g, water 500ml, strong aqua 30ml stir gradually moltenly entirely, drip the Calcium Chloride Powder Anhydrous aqueous solution, and gradually the adularescent solid is separated out, and again in stirred overnight at room temperature, filters after dripping off, and the aqueous ethanolic solution recrystallization gets calcium salt 65g, [α] D 20=+5.7 ° (C=1.0, methyl alcohol).

Claims (1)

1. the preparation method of a formula I compound (S)-2-benzyl Succinic Acid monocarboxylic acid derivative,
Figure C2005100376750002C1
It is characterized in that L-phenylalanine or its ester are made formula II (S)-2-halogeno-benzene propionic acid or ester through the diazotization halo:
Figure C2005100376750002C2
The active methylene reaction of formula II and formula III obtains formula IV:
Figure C2005100376750002C3
X is chlorine, bromine halogen atom among its Chinese style II, and Z and Z` are cyano group, ester group or amide group in the formula III, and R is hydrogen, ethyl in the structural formula of formula II or formula IV and L-phenylalanine or its ester;
Formula IV obtains formula V (S)-2-benzyl Succinic Acid through the hydrolysis decarboxylation reaction:
Formula V dehydration generates acid anhydrides and obtains formula I with the hexahydroisoindoline reaction again:
Figure C2005100376750002C5
CNB2005100376754A 2005-01-12 2005-01-12 Preparation of miglitol Expired - Fee Related CN1324010C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100376754A CN1324010C (en) 2005-01-12 2005-01-12 Preparation of miglitol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100376754A CN1324010C (en) 2005-01-12 2005-01-12 Preparation of miglitol

Publications (2)

Publication Number Publication Date
CN1680321A CN1680321A (en) 2005-10-12
CN1324010C true CN1324010C (en) 2007-07-04

Family

ID=35067162

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100376754A Expired - Fee Related CN1324010C (en) 2005-01-12 2005-01-12 Preparation of miglitol

Country Status (1)

Country Link
CN (1) CN1324010C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100441570C (en) * 2006-05-24 2008-12-10 严洁 Preparation of mitiglinide calcium and its quality control method
CN102382033B (en) * 2010-08-31 2013-04-03 凯瑞斯德生化(苏州)有限公司 Preparation methods for optical activity mitiglinide ester and mitiglinide salt
CN102911107B (en) * 2012-09-28 2015-11-25 迪沙药业集团有限公司 The preparation method of S 21403
CN104693109A (en) * 2013-12-05 2015-06-10 陕西师范大学 A preparing method of a miglitol intermediate
CN107879927A (en) * 2017-11-17 2018-04-06 中国药科大学 A kind of method for preparing α chlorinated carboxylic acids

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202335A (en) * 1991-03-30 1993-04-13 Kissei Pharmaceutical Co., Ltd. Succinic acid compounds
CN1261879A (en) * 1997-07-03 2000-08-02 阿迪尔公司 Method for preparing substituted perhydroisoindole
CN1320595A (en) * 2000-02-25 2001-11-07 阿迪尔公司 Process for preparing isoindoline
WO2003062186A1 (en) * 2002-01-22 2003-07-31 Kissei Pharmaceutical Co., Ltd. Metal salts of (3s)-3-methoxycarbonyl-4-phenylbutyric acid and usage thereof
CN1616427A (en) * 2003-11-13 2005-05-18 中国科学院上海药物研究所 A new method for preparing antidiabetic drug mitiglinide

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202335A (en) * 1991-03-30 1993-04-13 Kissei Pharmaceutical Co., Ltd. Succinic acid compounds
CN1261879A (en) * 1997-07-03 2000-08-02 阿迪尔公司 Method for preparing substituted perhydroisoindole
CN1320595A (en) * 2000-02-25 2001-11-07 阿迪尔公司 Process for preparing isoindoline
WO2003062186A1 (en) * 2002-01-22 2003-07-31 Kissei Pharmaceutical Co., Ltd. Metal salts of (3s)-3-methoxycarbonyl-4-phenylbutyric acid and usage thereof
CN1616427A (en) * 2003-11-13 2005-05-18 中国科学院上海药物研究所 A new method for preparing antidiabetic drug mitiglinide

Also Published As

Publication number Publication date
CN1680321A (en) 2005-10-12

Similar Documents

Publication Publication Date Title
CN1324010C (en) Preparation of miglitol
JPH0512355B2 (en)
CN106916060B (en) Preparation method of high-purity p-hydroxyacetophenone
WO2016062212A1 (en) Method for preparing 3-carbamoymethyl-5-methylhexanoic acid in recycling way
CN107501042B (en) Method for preparing isopropanol by hydrolyzing isopropyl acetate
CN109485745B (en) Preparation method and application of modified nitroxide free radical polymerization inhibitor
CN1636962A (en) Production method of multi-variety low-consumption plasticizer
CN101066912A (en) Process of preparing trans-polyhydroxy diphenyl ethylene
CN103183612A (en) Dipropylmalonic acid diester preparation method
CN101781264B (en) Production method of 1-methyl-5-mercapto-1,2,3,4-tetrazole
CN101353296A (en) Method for preparing (Z)-3'-hydroxy-3,4,4',5-tetramethoxy diphenyl ethylene from regenerative natural plant resource
CN111875495A (en) Synthetic method of octadecadienecarboxylic acid mono-tert-butyl ester
CN102816060B (en) The preparation method of high-purity clinofibrate
CN116640048A (en) Preparation method of 4,4' -biphenol
CN108341740A (en) A kind of preparation method to menthyl -3,8- glycol and its suitable, anti-configuration purification process
CN1626504A (en) Method for preparing Tolterodine and tartrate
CN111233683A (en) DL-propargyl glycine intermediate, preparation method thereof and preparation method of propargyl glycine based on intermediate
CN1239460C (en) Synthesis of trans-4-alkyl cyclohexyl formic acid
CN101585762B (en) Method for synthesizing 2-(4-cyclopropoxycarbonylphenyl)-2-methylpropanoic acid
CN101041618A (en) New production technique of cyclohexyl allyl propionate
CN1283605C (en) Process for preparing meta-trifluoromethyl benzyl alcohol
CN1762941A (en) Leaf alcohol synthesis method
CN102399141A (en) Preparation method of novel gefarnate key intermediate
CN101628879B (en) Preparation method of trans-4-acetamido cyclohexanol acetate
CN1247504C (en) Process for preparing beta-halogen-alpha-phenyl ethyl alcohol compounds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: JIANGSU PROVINCIAL INSTITUTE OF MATERIA MEDICA CO.

Free format text: FORMER OWNER: JIANGSU PROVINCIAL INSTITUTE OF MATERIA MEDICA

Effective date: 20101224

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20101224

Address after: 210009, Ma 26 street, Xuanwu Gate, Jiangsu, Nanjing

Patentee after: Jiangsu Provincial Institute of Materia Medica Co., Ltd.

Address before: 210009, Ma 26 street, Xuanwu Gate, Jiangsu, Nanjing

Patentee before: Jiangsu Provincial Institute of Materia Medica

EE01 Entry into force of recordation of patent licensing contract

Assignee: Changzhou Tianhua Pharmaceutical Co., Ltd.

Assignor: Jiangsu Provincial Institute of Materia Medica Co., Ltd.

Contract record no.: 2011320000025

Denomination of invention: Preparation of miglitol

Granted publication date: 20070704

License type: Exclusive License

Open date: 20051012

Record date: 20110127

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070704

Termination date: 20120112